A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

Clinical trial NCT06828991 · RECRUITING

Trial details

NCT number

NCT06828991

Sponsor

Danielle Wallace

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2025-09-04

Primary completion

2029-04-01

Enrollment

40

View on ClinicalTrials.gov